PWC
MDT icon

Pathfinder Wealth Consulting’s Medtronic MDT Stock Holding History

Pathfinder Wealth Consulting’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,435
Closed -$298K – 92
2026
Q1 		$298K Sell
3,435
-9
-0.3% -$862 0.19% 113
2025
Q4 		$331K Buy
+3,444
New +$335K 0.21% 103

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Pathfinder Wealth Consulting's MDT Position: Q2 2026 in Review

Pathfinder Wealth Consulting sold out of Medtronic (MDT) in Q2 2026, closing a stake of 3,435 shares — an estimated $298K sold.

Pathfinder Wealth Consulting first reported a position in MDT in Q4 2025 and held it in 2 quarters. The position peaked at $331K in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Pathfinder Wealth Consulting reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Pathfinder Wealth Consulting sold 3,435 Medtronic shares in Q2 2026, an estimated $298K.
  • Pathfinder Wealth Consulting first reported a position in Medtronic in Q4 2025 and held it in 2 quarters.
  • Pathfinder Wealth Consulting's Medtronic position peaked at $331K in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Pathfinder Wealth Consulting's 13F filing for Q2 2026.